![Joseph Gilliam](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Gilliam
President at
GLAUKOS CORPORATION
Net worth: 8 M $ as of 2026-05-30
Profile
Joseph E.
Gilliam is currently Independent Director at Caris Life Sciences, Inc. since 2021, Director at Avedro, Inc. since 2019, and President & Chief Operating Officer at Glaukos Corp.
since 2022.
Formerly, Mr. Gilliam was Managing Director-Healthcare Investment Banking at JPMorgan Chase & Co. from 2013 to 2017.
Mr. Gilliam completed undergraduate studies at Kelley School of Business in 1998.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
GLAUKOS CORP 0.13% | 2026-04-30 | 73,419 ( 0.13% ) | 8 M $ | 2026-05-30 |
| 2026-03-30 | 0 ( -.--% ) | - $ | 2026-05-30 |
Joseph Gilliam active positions
| Companies | Position | Start |
|---|---|---|
| GLAUKOS CORPORATION | President | 2022-03-31 |
| AVEDRO, INC. | Director/Board Member | 2019-11-20 |
| CARIS LIFE SCIENCES, INC. | Director/Board Member | 2021-03-31 |
Former positions of Joseph Gilliam
| Companies | Position | End |
|---|---|---|
| JPMORGAN CHASE & CO. | Corporate Officer/Principal | 2017-04-30 |
Training of Joseph Gilliam
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
89
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
JPMorgan Chase & Co.
 JPMorgan Chase & Co. Major BanksFinance Provides banking, asset management, investment banking, credit card and mortgage services | Finance |
Avedro, Inc.
 Avedro, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ophthalmic pharmaceuticals & medical devices | Health Technology |
Glaukos Corp.
 Glaukos Corp. Medical SpecialtiesHealth Technology Operates as an ophthalmic medical device company | Health Technology |
Caris Life Sciences, LLC
 Caris Life Sciences, LLC BiotechnologyHealth Technology Operates as an AI-powered biotech company that provides molecular profiling services to develop oncology pharmaceuticals with proprietary platform | Health Technology |
Kelley School of Business
 Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Joseph Gilliam
